Yeast has been used extensively as a model system to study human neurodegenerative diseases including Huntington disease, Parkinson disease, Alzheimer disease, amyotrophic lateral sclerosis, and mad cow disease (1) . In all of these diseases, protein misfolding leads to the generation of amyloid plaque formation. One of the best characterized misfolding diseases is Huntington disease, which is caused by the misfolding of a fragment of huntingtin protein when these fragments have more than 35-40 glutamines in their polyQ repeat region. Although aggregate formation has been associated with neurotoxicity, several recent studies in mammalian cells have shown that it is the diffuse intracellular huntingtin (Htt) 3 fragments that are the toxic species, whereas the inclusion, referred to as an aggresome (2) , is in fact neuroprotective (3, 4) . The aggresome, a large aggregate containing misfolded proteins as well as intermediate filaments, is formed by the misfolded proteins traveling along the microtubules to the centrosome. As to the nature of the diffuse Htt species causing toxicity in mammalian cells, this has been attributed to both misfolded monomers and soluble oligomers (4 -8) . The oligomers form prior to the fibrils (9) , which then are organized into the amyloid plaque.
Studies extending the Huntington disease model to yeast showed that the formation of Htt aggregates is dependent on the length of the polyQ repeat region in the expressed fragments, just as was observed in mammalian cells (10) . However, unlike mammalian cells, neither a long polyQ repeat region nor the presence of visible oligomers is sufficient to cause toxicity in yeast even though toxicity only occurs when Htt with expanded polyQ repeat regions forms visible aggregates (10, 11) . Instead, the aggregation of Htt fragments is generally dependent on the yeast having one of its many prion proteins in the amyloid conformation (10) . So far 10 prions have been identified in yeast, the most common of them are [PSI ϩ ], [URE3], and [PIN ϩ ] (12). These yeast prions contain an asparagine/glutamine-rich domain, which is prone to misfold into an amyloid conformation. The propagation of this amyloid conformation requires the molecular chaperone, Hsp104; inactivation of Hsp104 activity cures yeast of the prion phenotype. In these cured cells, regardless of the length of their polyQ repeat regions, the expressed Htt fragments are non-toxic (10, 11) .
When Htt fragments with an expanded polyQ repeat region are expressed in yeast containing a misfolded prion, they form either multiple aggregates or one large aggregate, recently identified as an aggresome (13) . Multiple aggregates of Htt fragments in the yeast cytosol can be toxic whereas no Htt toxicity has been associated with the Htt aggresome (13) , suggesting that the aggresome is protective, just as has been proposed for mammalian cells. Aggresomes only occur when the Htt fragments with an expanded polyQ repeat region also have a polyproline region downstream of the polyQ repeat region. However, not all Htt polyQ fragments with a polyproline region form an aggresome, which shows the importance of amino acids flanking the Htt fragment (14) . Furthermore, even when Htt fragments with expanded polyQ repeat regions form multiple aggregates, whether the fragment is toxic depends on the amino acids flanking the polyQ repeat region (14) . For example, the HttQ103-GFP fragment without an epitope tag is not toxic, but the same fragment with an N-terminal FLAG-epitope is toxic. This latter fragment has been used extensively in many yeast studies to better characterize the toxic nature of Htt fragments with expanded polyQ repeat regions (13, (15) (16) (17) (18) (19) .
The toxic effect of multiple Htt aggregates appears to be due to the sequestration of proteins that have a polyQ repeat region by the Htt aggregates (20) . Among the proteins that are sequestered in Htt aggregates are endocytic proteins such as Pan1 and Sla1 (17, 18 (17, 19) . However, the relationship between the endocytosis defect and toxicity has not been clearly defined since many of the proteins that affect endocytosis in yeast also affect the actin cytoskeleton. Therefore, which protein or proteins are sequestered and why this causes toxicity is unclear.
In Expression of a C-terminal fragment of Sup35 essential for Sup35 function markedly rescued HttQP103 toxicity, but was less effective in rescuing HttQ103 toxicity. These results establish that in [PSI ϩ ] yeast, the sequestration of the translation termination factor, Sup35, is a major factor contributing to the toxicity of HttQP103. This is the first defined protein of sequestration by Htt fragments that has been shown to cause toxicity in yeast. Michael Sherman (Boston University School of Medicine) under the control of the GAL1 promoter cloned in the pYES2 vector as described previously (13, 18) . The different Htt fragments, HttQ25, HttQP25, HttQ103, and HttQP103, were expressed with a FLAG tag at its N terminus and a GFP at its C terminus. The MC fragment of Sup35 was expressed from a LEU2-based centromeric plasmid pJ528-MC (22) , which is under the control of SUP35 promoter (500 bp) and fused to SUP35 terminator (200 bp of 3Ј-UTR). Sup45 was expressed from the SUP45 promoter from a TRP1-based centromeric plasmid (gift from S. Liebman, University of Illinois). RNQ1 was deleted in weak and strong [PSI ϩ ] strains by using homolog recombination of a PCR-amplified KanMX disruption cassette from a yeast deletion strain (ATCC). The ⌬rnq1 strain was verified by PCR and Western analysis using an anti-Rnq1 polyclonal antibody from Dr. E. Craig (data not shown).
EXPERIMENTAL PROCEDURES
Observation of Yeast Growth and Induction-Yeast were grown at 30°C on synthetic medium (SD; 0.7% yeast nitrogen base, 2% glucose) with complete supplement mixture (CSM) or the appropriate amino acid dropout supplement mixture. Galactose medium contains both 2% galactose and 2% raffinose in place of glucose. Strains having 2 micron URA3-based empty vector or plasmids containing the galactose-inducible Htt fragments were grown in SD-Ura medium to mid-log phase and then washed out twice in synthetic galactose medium without uracil (SGal-Ura) to remove residual glucose. To determine toxicity using the spot assay, cells in SGal-Ura medium (A 600 ϭ 0.5) were serially diluted 5-fold. The serial dilutions (5 l) were plated onto a SGal-Ura plate with limited adenine. In analyzing the growth of yeast that expressed both the MC fragment of Sup35 and Htt fragments, cells with serial dilution were plated onto SGal-Ura-Leu plate with limited adenine. Images of the plates were taken after incubation of the plates for 6 days at 30°C. To determine growth, the same number of cells calculated from optical density was plated on duplicate SD selection plates. The colonies that grew on the selection plates were counted after incubation at 30°C for 6 days. All growth curves were from 3 independent experiments and for each time point, the average value and standard deviation are plotted.
Staining of Cells with PI-Yeast were suspended in PBS at A 600 ϭ 0.2. This yeast suspension (300 l) was mixed with 4 l of a stock 1 mg/ml PI solution (Sigma). Following incubation at room temperature for 30 min, the yeast were either imaged by confocal microscopy or analyzed for fluorescence by FACs.
Confocal Microscopy-Zeiss LSM 510 confocal microscope with a 100ϫ objective was used to acquire fluorescence, PI staining, and DIC images simultaneously. GFP-Htt and PI were imaged using the 488-nm laser and the 543-nm laser, respectively. Cells were imaged in eight-well 25-mm 2 chambered coverslips (Lab-Tek, Rochester) using the identical settings for all images. Cells were imaged 23 h after induction of expression of the Htt fragments by growing cells in SGal medium.
Western Blot Analysis-Cell lysis and Western blotting were performed as described previously with minor modifications (23) . The following antibodies were used: a polyclonal rabbit anti-Sup35 antibody made in our laboratory and anti-Pgk1 monoclonal antibody (Molecular Probes, Carlsbad, CA). Rnq1 was probed using an anti-Rnq1 polyclonal antibody (gift from E. Craig, Univ. of Wisconsin). Odyssey dye800-conjugated goat and dye800-conjugated donkey anti-mouse antibody were used as secondary antibody. Odyssey scanner and software have been used for detection of bands and quantitation of the intensity of bands on the blots represented in figures.
FACS Analysis-Yeast were precultured in glucose selection medium overnight before they were transferred into galactose selection medium to induce HttQ103 and HttQP103 expression. After 22 h in galactose medium, cells were collected by centrifugation, washed once with PBS, and then stained with propodium iodide. FACS analysis on the BD FACS Calibur was used to determine the percent of propodium iodide-positive cells in the yeast population. , and HttQP103 fragments were expressed under the control of the GAL1 promoter. These fragments differ in the number of polyglutamines (25 versus 103) and the presence of a polyproline region at the C terminus. The effect of expressing these Htt fragments was examined using a spot assay in which the yeast were serially diluted on selection plates containing galactose to induce expression of the Htt fragments ( Fig. 2A) ] yeast to determine whether their different toxicities were related to differences in aggregation. However, these fragments formed aggregates in all cells with similar appearance regardless of the prion variant present (Fig. 3) . DIC staining showed that not all of the yeast cells were expressing GFP-labeled HttQ103 or HttQP103, which would explain the lack of growth of these cells when plated on selection plates. Evidently, the cells with the GFP-Htt aggregates are not proliferating, while the non-fluorescent cells are dying out with time in the selection medium. ] yeast were transformed with a plasmid that constitutively expresses the MC fragment of Sup35 from the SUP35 promoter to determine if this truncated fragment rescues Htt toxicity. Importantly, this MC fragment contains the C-terminal domain of Sup35, which is essential for translation termination, but lacks the N-terminal prion-forming domain. The effect of constitutive expression of the MC fragment on Htt toxicity was analyzed using the spot assay. As shown in Fig.  4A ] variant, the growth rate of yeast expressing HttQ103 and MC was about 25% of the control rate, while the growth rate of yeast expressing HttQP103 and MC was about 75% of the control rate. These results confirm that MC rescues HttQP103 toxicity to a much greater extent than HttQ103 toxicity. To rule out that the difference in the extent of rescue is due to the expression level of MC, Western blot analysis was performed to measure the amount of MC using a polyclonal antibody that recognizes both MC and Sup35. Fig. 4C shows comparable levels of the MC fragment in control cells and cells expressing Htt fragments, after normalizing for protein levels using Pgk1 as an internal control. Furthermore, unlike full-length Sup35, the MC fragment remains in the supernatant after high speed centrifugation, which shows that a 
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limiting amount of MC does not account for the lack of complete rescue.
We also tested whether Htt toxicity is rescued by expressing Sup45 since Sup45 is an essential protein that forms a complex with Sup35 in translation termination (26 (Fig. 5A) The toxic effects of the Htt fragments also depended on the presence or absence of the polyproline region. HttQ103 was more toxic than HttQP103 regardless of the [PSI ϩ ] variant, as shown by the growth curves (Fig. 5B) ]yeast were transformed with the Htt plasmids and the toxicity of the Htt fragments was then analyzed using the spot assay. Fig. 7A shows the expression of HttQ103, but not HttQP103, caused a significant reduction in the growth of the [PIN ϩ ] yeast, in agreement with the results from the Sherman laboratory (18) . These results were confirmed by the growth curves (Fig. 7B) (Fig. 3) . Interestingly, even though the expression of HttQ103 and HttQP103 caused very different levels of toxicity in [psi Ϫ ]/[PIN ϩ ] yeast, the Htt aggregates had a similar appearance with multiple HttQ103 and HttQP103 aggregates present in the cytosol (Fig. 7C) . The cells did not show one prominent aggregate characteristic of an aggresome (13) nor were there diffuse cells present in the population as occurred when yeast had only the [PSI ϩ ] prion. Therefore, gross differences in the appearance of the aggregates do not explain the differences in the observed toxicity. Instead, HttQ103 and HttQP103 amyloids must differ in their conformations to account for the differences in their sequestration of essential proteins and thus their toxicity.
DISCUSSION
The expression of Htt fragments in yeast has been used to investigate the pathophysiology of Hungtinton disease. Surprisingly, the relationship between toxicity and the aggregation of the Htt fragments with pathologically long polyQ repeat regions (Ͼ40 polyQ) in the cytosol has proven to be more complex in yeast than in mammalian cells. In mammalian cells, the longer the polyQ repeat region, the greater the toxicity. Furthermore, recent data have suggested that, rather than the aggregate itself, it is the amount of diffuse intracellular Htt fragments (3, 27) , that is both monomers and soluble oligomers of the Htt fragments, that apparently causes toxicity in mammalian cells (4, 5, 27 ] variant even though Htt aggregates were present in the majority of cells in both the weak and strong variants. To determine whether this toxicity was caused by the sequestration of Sup35, we tested whether the C-terminal fragment of Sup35 could rescue toxicity. The constitutive expression of the MC fragment of Sup35 markedly rescued HttQP103 toxicity, but was less effective in rescuing HttQ103 toxicity. Evidently, sequestration of other essential proteins is contributing more to the toxicity caused by HttQ103 than by HttQP103. As for HttQP103, its toxicity is mostly due to sequestration of Sup35, which indicates that the polyproline region of HttQP103 must be involved in Sup35 sequestration. Toxicity due to sequestration of Sup35 in [PSI ϩ ] yeast has also been observed when the Sup35 fragment, NMG (the N-terminal Gln/Asn-rich domain plus the middle domain of Sup35 fused to GFP), was overexpressed (21) . Like the toxicity caused by HttQP103, toxicity due to NMG overexpression was rescued by expressing the C-terminal domain of Sup35. In addition, the Wickner laboratory has shown that an unusually strong [PSI ϩ ] phenotype causes lethality due to insufficient free Sup35 in the cytosol (28) .
Our results show that the molecular basis of the toxicity caused by expression of Htt fragments in yeast is quite complex. First, this study showed that in addition to the HttQ103 fragment being toxic, in agreement with previous studies (11, The complex molecular basis of Huntington disease is also evident from studies on mammalian cells. Just as in yeast, Htt aggregates have been shown to sequester many different proteins including CBP, a coactivator of the transcription factor CREB, SP1, a transcriptional factor, and the Gln-Ala repeat transcriptional coactivator CA150 (29) . Our yeast data suggest that the protein sequestered by the Htt aggregates may differ depending on whether the Htt fragments contain a polyproline region. In addition the toxicity caused by Htt may be dependent on the conformation of the misfolded protein. Not only Htt inclusions (30) , but also misfolded monomer and soluble oligomers have been shown to be toxic to the cell (3) (4) (5) . Even soluble Htt oligomers have been shown to exist in several conformations (6), which may lead to sequestration of different proteins in the cell. Importantly, Huntington disease belongs to a family of polyglutamine neurodegenerative diseases, which are all caused by an expanded polyQ repeat region. These different diseases affect different neurons, which may be due to the fact that different neurons require different levels of particular essential proteins. This complex molecular basis of Huntington disease may explain why it has been so difficult to understand the pathogenesis of polyglutamine disease in mammalian cells. 
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